Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Capital Employed (2022 - 2026)

TriSalus Life Sciences has reported Return on Capital Employed over the past 5 years, most recently at 67.75% for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 15103.0% year-over-year to 67.75%; the TTM value through Mar 2026 reached 67.75%, up 15103.0%, while the annual FY2025 figure was 148.45%, 10884.0% up from the prior year.
  • Return on Capital Employed for Q1 2026 was 67.75% at TriSalus Life Sciences, up from 110.44% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 19.98% in Q4 2022 and troughed at 817.14% in Q1 2024.
  • A 5-year average of 261.26% and a median of 216.28% in 2024 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: crashed -63458bps in 2024 and later skyrocketed 59836bps in 2025.
  • Year by year, Return on Capital Employed stood at 19.98% in 2022, then plummeted by -1793bps to 378.2% in 2023, then skyrocketed by 38bps to 233.38% in 2024, then skyrocketed by 53bps to 110.44% in 2025, then surged by 39bps to 67.75% in 2026.
  • Business Quant data shows Return on Capital Employed for TLSI at 67.75% in Q1 2026, 110.44% in Q4 2025, and 111.7% in Q3 2025.